FORM 13F
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Form 13F COVER PAGE
Report for the Calendar Year or Quarter Ended: March 31, 1999
Check here if Amendment [ ]: Amendment Number: ______________
This Amendment (Check only one.):
[ ] is a restatement.
[ ] adds new holdings entries.
Institutional Investment Manager Filing this Report:
Name: Hambrecht & Quist Capital Management
Address: 50 Rowes Wharf, Boston, MA 02110
Form 13F File Number:
The institutional investment manager filing this report and
the person by whom it is signed hereby represent that the person
signing the report is authorized to submit it, that all
information contained herein is true, correct and complete, and
that it is understood that all required items, statements,
schedules, lists and tables, are considered integral parts of this
form.
Person Signing this Report on Behalf of Reporting Manager:
Name: Kim Carroll
-------------------------------------------------------------------------
Title: Vice President
Phone: (617) 310-0537
-------------------------------------------------------------------------
Signature, Place and Date of Signing:
/s/ Kim Carroll
- --------------------------------------------------------------------------------
(Signature)
Boston, MA
- --------------------------------------------------------------------------------
(City, State)
May 13, 1999
- --------------------------------------------------------------------------------
(Date)
All securities with respect to which Hambrecht & Quist Capital Management
exercises investment discretion are being reported by Hambrecht & Quist Cap
Management, 50 Rowes Wharf, Boston, MA 02110.
<PAGE>
Report Type (Check only one):
|X| 13F HOLDINGS REPORT. (Check here if all holdings of this reporting manager
are reported in this report.)
|_| 13F NOTICE. (Check here if no holdings reported are in this report, and all
holdings are reported by other reporting manager(s).
|_| 13F COMBINATION REPORT. (Check here if a portion of the holdings for this
reporting manager are reported in this report and a portion are reported by
other reporting manager(s).)
Form 13F Summary Page
Report Summary:
Number of Other Included Managers: 0
Form 13F Information Table Entry Total: 48
Form 13F Information Table Value Total: $200,761,997 (million)
List of Other Included Managers:
Provide a numbered list of the name(s) and Form 13F file number(s)
of all institutional investment managers with respect to which this
report is filed, other than the manager filing this report. [If there
are no entries in this list, state "NONE" and omit the column headings
and list entries.]
No.
-----------------------------------------------------------------------------
Form 13F File Number
-----------------------------------------------------------
Name
--------------------------------------------------------------------------
<PAGE>
FORM 13F
<TABLE>
<CAPTION>
(SEC USE ONLY)
Page of Name of Reporting Manager: HAMBRECHT & QUIST CAPITAL MANAGEMENT
- ------------------------------------------------------------------------------------------------------------------------------------
Item 5: Item 6:
Item 1: Item 2: Item 3: Item 4: Shares of Investment Discretion
Name of Issuer Title of Class CUSIP Fair Market Principal (b) Shared-
Number Value Amount (a) Sole As Defined (c) Shared
in Instr. V Other
- ------------------------------------------------------------------------------------------------------------------------------------
<S> <C> <C> <C> <C> <C> <C> <C>
- ------------------------------------------------------------------------------------------------------------------------------------
Aradigm Common O3850510 3,193,750 350,000 X
- ------------------------------------------------------------------------------------------------------------------------------------
Biofield Common O90591207 109,846 878,774 X
- ------------------------------------------------------------------------------------------------------------------------------------
Biogen Common O9059710 4,000,938 35,000 X
- ------------------------------------------------------------------------------------------------------------------------------------
Bioject Medical Technologies Common 09059T107 933,375 1,468,400 X
- ------------------------------------------------------------------------------------------------------------------------------------
Biomatrix Common 09060P102 10,874,760 139,420 X
- ------------------------------------------------------------------------------------------------------------------------------------
BioTransplant Common 09066Y107 1,558,633 712,519 X
- ------------------------------------------------------------------------------------------------------------------------------------
Biovail Common 09067K106 4,196,500 109,000 X
- ------------------------------------------------------------------------------------------------------------------------------------
Calypte Biomedical Common 131722100 3,988,293 1,433,993 X
- ------------------------------------------------------------------------------------------------------------------------------------
Catalytica Common 148885106 13,273,326 1,206,666 X
- ------------------------------------------------------------------------------------------------------------------------------------
Centocor Common 152342101 4,070,000 110,000 X
- ------------------------------------------------------------------------------------------------------------------------------------
Cor Therapeutics Common 217753102 2,850,000 285,000 X
- ------------------------------------------------------------------------------------------------------------------------------------
Coulter Pharmaceutical Common 222116105 5,577,500 257,500 X
- ------------------------------------------------------------------------------------------------------------------------------------
Cubist Pharmaceuticals Common 229990981 5,064,078 1,620,505 X
- ------------------------------------------------------------------------------------------------------------------------------------
CV Therapeutics Common 126667104 2,577,032 533,750 X
- ------------------------------------------------------------------------------------------------------------------------------------
Cytyc Common 232946103 4,667,404 334,880 X
- ------------------------------------------------------------------------------------------------------------------------------------
Emisphere Technologies Common 291345106 1,359,000 151,000 X
- ------------------------------------------------------------------------------------------------------------------------------------
Envirogen Common 294040100 34,505 20,833 X
- ------------------------------------------------------------------------------------------------------------------------------------
EP Med Systems Common 26899B914 2,956,250 1,075,000 X
- ------------------------------------------------------------------------------------------------------------------------------------
Exogen Common 302092101 734,156 286,500 X
- ------------------------------------------------------------------------------------------------------------------------------------
Focal Common 343909107 1,903,839 271,977 X
- ------------------------------------------------------------------------------------------------------------------------------------
Fuisz Technologies Common 359536109 4,331,251 660,000 X
- ------------------------------------------------------------------------------------------------------------------------------------
Gene Logic Common 368689105 1,706,250 350,000 X
- ------------------------------------------------------------------------------------------------------------------------------------
Gilead Sciences Common 37555B103 16,227,985 356,659 X
- ------------------------------------------------------------------------------------------------------------------------------------
IDEXX Laboratories Common 45168D104 6,031,250 250,000 X
- ------------------------------------------------------------------------------------------------------------------------------------
INCYTE Pharmaceuticals Common 45337C102 2,487,751 124,000 X
- ------------------------------------------------------------------------------------------------------------------------------------
Interpore Cross Common 46062W107 1,710,000 380,000 X
- ------------------------------------------------------------------------------------------------------------------------------------
KeraVision Common 648990992 3,144,321 206,185 X
- ------------------------------------------------------------------------------------------------------------------------------------
Landec Common 514766104 2,124,345 566,492 X
- ------------------------------------------------------------------------------------------------------------------------------------
LJL BioSystems Common 501873103 850,000 200,000 X
- ------------------------------------------------------------------------------------------------------------------------------------
LJL BioSystems (Restricted) Common 501873103 2,292,311 769,230 X
- ------------------------------------------------------------------------------------------------------------------------------------
Lynx Therapeutics Common 551812308 3,492,188 375,000 X
- ------------------------------------------------------------------------------------------------------------------------------------
Martek Biosciences Common 572901106 4,388,760 780,224 X
- ------------------------------------------------------------------------------------------------------------------------------------
MedImmune Common 584699102 6,510,625 110,000 X
- ------------------------------------------------------------------------------------------------------------------------------------
NeoPath Common 640517108 1,142,308 276,923 X
- ------------------------------------------------------------------------------------------------------------------------------------
Neurogen Common 64124E1O6 1,710,000 160,000 X
- ------------------------------------------------------------------------------------------------------------------------------------
Novoste Common 67010C100 601,563 25,000 X
- ------------------------------------------------------------------------------------------------------------------------------------
Perclose Common 71361C107 8,277,000 267,000 X
- ------------------------------------------------------------------------------------------------------------------------------------
Quintiles Transnational Common 748767100 11,434,475 302,900 X
- ------------------------------------------------------------------------------------------------------------------------------------
Ribi ImmunoChem Research Common 762553105 1,258,592 745,832 X
- ------------------------------------------------------------------------------------------------------------------------------------
Sepracor Common 817315104 20,044,370 178,569 X
- ------------------------------------------------------------------------------------------------------------------------------------
<CAPTION>
(SEC USE ONLY)
Page of Name of Reporting Manager: HAMBRECHT & QUIST CAPITAL MANAGEMENT
- ------------------------------------------------------------------------------------------------------------------------------------
Item 8:
Voting Authority (Shares)
-----------------------------
Item 1: Item 7:
Name of Issuer Managers
See Instr. V (a) Sole (b) Shared (c) None
- -----------------------------------------------------------------------------------
<S> <C> <C> <C> <C>
- -----------------------------------------------------------------------------------
Aradigm NA X
- -----------------------------------------------------------------------------------
Biofield NA X
- -----------------------------------------------------------------------------------
Biogen NA X
- -----------------------------------------------------------------------------------
Bioject Medical Technologies NA X
- -----------------------------------------------------------------------------------
Biomatrix NA X
- -----------------------------------------------------------------------------------
BioTransplant NA X
- -----------------------------------------------------------------------------------
Biovail NA X
- -----------------------------------------------------------------------------------
Calypte Biomedical NA X
- -----------------------------------------------------------------------------------
Catalytica NA X
- -----------------------------------------------------------------------------------
Centocor NA X
- -----------------------------------------------------------------------------------
Cor Therapeutics NA X
- -----------------------------------------------------------------------------------
Coulter Pharmaceutical NA X
- -----------------------------------------------------------------------------------
Cubist Pharmaceuticals NA X
- -----------------------------------------------------------------------------------
CV Therapeutics NA X
- -----------------------------------------------------------------------------------
Cytyc NA X
- -----------------------------------------------------------------------------------
Emisphere Technologies NA X
- -----------------------------------------------------------------------------------
Envirogen NA X
- -----------------------------------------------------------------------------------
EP Med Systems NA X
- -----------------------------------------------------------------------------------
Exogen NA X
- -----------------------------------------------------------------------------------
Focal NA X
- -----------------------------------------------------------------------------------
Fuisz Technologies NA X
- -----------------------------------------------------------------------------------
Gene Logic NA X
- -----------------------------------------------------------------------------------
Gilead Sciences NA X
- -----------------------------------------------------------------------------------
IDEXX Laboratories NA X
- -----------------------------------------------------------------------------------
INCYTE Pharmaceuticals NA X
- -----------------------------------------------------------------------------------
Interpore Cross NA X
- -----------------------------------------------------------------------------------
KeraVision NA X
- -----------------------------------------------------------------------------------
Landec NA X
- -----------------------------------------------------------------------------------
LJL BioSystems NA X
- -----------------------------------------------------------------------------------
LJL BioSystems (Restricted) NA X
- -----------------------------------------------------------------------------------
Lynx Therapeutics NA X
- -----------------------------------------------------------------------------------
Martek Biosciences NA X
- -----------------------------------------------------------------------------------
MedImmune NA X
- -----------------------------------------------------------------------------------
NeoPath NA X
- -----------------------------------------------------------------------------------
Neurogen NA X
- -----------------------------------------------------------------------------------
Novoste NA X
- -----------------------------------------------------------------------------------
Perclose NA X
- -----------------------------------------------------------------------------------
Quintiles Transnational NA X
- -----------------------------------------------------------------------------------
Ribi ImmunoChem Research NA X
- -----------------------------------------------------------------------------------
Sepracor NA X
- -----------------------------------------------------------------------------------
</TABLE>
<PAGE>
FORM 13F
<TABLE>
<CAPTION>
(SEC USE ONLY)
Page of Name of Reporting Manager: HAMBRECHT & QUIST CAPITAL MANAGEMENT
- ------------------------------------------------------------------------------------------------------------------------------------
Item 5: Item 6:
Item 1: Item 2: Item 3: Item 4: Shares of Investment Discretion
Name of Issuer Title of Class CUSIP Fair Market Principal (b) Shared-
Number Value Amount (a) Sole As Defined (c) Shared
in Instr. V Other
- ------------------------------------------------------------------------------------------------------------------------------------
<S> <C> <C> <C> <C> <C> <C> <C>
Synaptic Pharmaceutical Common 871990982 1,300,782 187,500 X
- ------------------------------------------------------------------------------------------------------------------------------------
Teva Pharmaceutical Industries Common 88162420 2,376,546 50,000 X
- ------------------------------------------------------------------------------------------------------------------------------------
Transkaryotic Therapies Common 893735100 15,317,597 482,444 X
- ------------------------------------------------------------------------------------------------------------------------------------
Transkaryotic Therapies
(Restricted) Common 893735100 612,292 24,106 X
- ------------------------------------------------------------------------------------------------------------------------------------
Triangle Pharmaceuticals Common 89589H104 3,206,250 300,000 X
- ------------------------------------------------------------------------------------------------------------------------------------
Trimeris Common 89626310 1,466,250 115,000 X
- ------------------------------------------------------------------------------------------------------------------------------------
Verdant Brands Common 923366108 213,750 190,000 X
- ------------------------------------------------------------------------------------------------------------------------------------
Vivus Common 928551100 2,580,000 645,000 X
- ------------------------------------------------------------------------------------------------------------------------------------
COLUMN TOTALS 200,761,997
- ------------------------------------------------------------------------------------------------------------------------------------
<CAPTION>
(SEC USE ONLY)
Page of Name of Reporting Manager: HAMBRECHT & QUIST CAPITAL MANAGEMENT
- ------------------------------------------------------------------------------------------------------------------------------------
Item 8:
Voting Authority (Shares)
-----------------------------
Item 1: Item 7:
Name of Issuer Managers
See Instr. V (a) Sole (b) Shared (c) None
- ---------------------------------------------------------------------------------------
<S> <C> <C> <C> <C>
Synaptic Pharmaceutical NA X
- ---------------------------------------------------------------------------------------
Teva Pharmaceutical Industries NA X
- ---------------------------------------------------------------------------------------
Transkaryotic Therapies NA X
- ---------------------------------------------------------------------------------------
Transkaryotic Therapies
(Restricted) NA X
- ---------------------------------------------------------------------------------------
Triangle Pharmaceuticals NA X
- ---------------------------------------------------------------------------------------
Trimeris NA X
- ---------------------------------------------------------------------------------------
Verdant Brands NA X
- ---------------------------------------------------------------------------------------
Vivus NA X
- ---------------------------------------------------------------------------------------
COLUMN TOTALS
- ---------------------------------------------------------------------------------------
</TABLE>
